Weekly Digest: Apr 20 - Apr 24, 2026
A curated summary of the top protein engineering and structure prediction signals from Apr 20 - Apr 24, 2026.

Building something in Protein Design?
I love collaborating on new challenges. Let's build together.
Subscribe to Protein Design Digest
Daily curated signals from arXiv, PubMed, and BioRxiv.
🧬 Weekly Recap
Apr 20 - Apr 24, 2026
Missed a day? Here are the top research signals and tools from Monday to Friday, summarized in one place.
🏆 Top Signals of the Week
🗓️ Monday, Apr 20
Advancing protein engineering via organic chemistry.
🧬 Abstract
Proteins are central to nearly all biological processes; their functions are tightly regulated by dynamic mechanisms such as covalent alterations; e.g., post-translational modifications (PTMs). These modifications can influence the protein’s structure, localization, and activity. Inspired by this diversity and regulation, advances in synthetic organic chemistry have enabled the production of a plethora of novel proteins for both basic research and biomedical applications. Recent progress in structural elucidation technologies and modern organic chemistry has enabled atom-level modifications, significantly enhancing our ability to tailor protein function. These approaches greatly expand the toolkit currently available for generating complex proteins with unique structural and functional properties. In this review, we summarize recent progress in chemical protein engineering and highlight its emerging applications in catalysis, functional studies, and drug development.
🗓️ Thursday, Apr 23
NNDock2: A neural network-based scoring function for ranking protein-protein docking models.
🧬 Abstract
Protein-protein interactions (PPIs) play crucial roles in diverse cellular functions and biological processes, and structural knowledge of the protein complexes is valuable for the elucidation of those functions and designing new drugs. Due to the limitations of experimental methods, computational modeling approaches capable of producing reliable protein complex models using molecular docking tools are of considerable practical interest. The success of protein docking largely depends on an accurate scoring function that can pick out good protein docking models. In this work, we present a neural network-based scoring function for scoring protein-protein docking models, NNDock2, the updated version of our previous scoring function, NNDock1. To improve NNDock1, we augmented the training decoys by adding a large number of more distant decoys. In addition, instead of interface root mean square deviation (iRMSD) in NNDock1, we used the fraction of native contact ([Formula: see text] as a target function, which shows better correlation with true model quality. We also applied regularization during training to avoid overfitting. We tested NNDock2 on the protein-protein docking benchmark version 5.0 (BM5), DOCKGROUND dataset, and the CAPRI score set and compared the performance of NNDock2 with other state-of-the-art scoring functions. NNDock2 performed comparably to other state-of-the-art scoring functions, despite the simplicity of the method and low computational costs. We envision that NNDock2 could be used as an independent scoring function or as an element or feature of composite or deep learning-based scoring functions for protein complex model quality estimation.
Why it matters: Expands the searchable sequence space for novel folds and high-affinity binders.
🗓️ Friday, Apr 24
Enhancing CYP450-Ligand Binding Predictions: A Comparative Analysis of Ligand-Based and Hybrid Machine Learning Models.
🧬 Abstract
Predicting cytochrome P450 (CYP450) ligand binding is critical in early-stage drug discovery as CYP450-mediated metabolism profoundly influences drug efficacy, safety, and adverse reaction risks. However, experimental determination of CYP450-ligand interactions remains resource- and time-intensive, underscoring the need for robust computational alternatives. While ligand-based methods are commonly employed, they often fail to fully account for structural intricacies governing protein-ligand interactions. To address this gap, we developed a hybrid machine learning framework integrating ligand descriptors, protein descriptors, and protein-ligand interaction descriptors that include molecular docking-derived parameters, rescoring function components from multiple algorithms, and structural interaction fingerprints (SIFt). Evaluated on CYP1A2 and CYP17A1 isoforms, our model demonstrated superior predictive accuracy in cross-validation compared with stand-alone molecular docking and ligand-based approaches. Furthermore, benchmarking against state-of-the-art tools (SwissADME and ADMETlab 3.0) revealed enhanced performance in binding prediction. This work establishes a versatile framework for advancing computational tools to prioritize CYP450 binding assessments during drug discovery.
Why it matters: Essential ground-truth data for validating next-gen foundation models like Boltz or Chai.
📚 All Papers & Quick Reads
🗓️ Monday, Apr 20
- Molecular docking: a computational approach for the discovery of novel targets against visceral leishmaniasis.: Context The protozoan parasite Leishmania donovani is a major causative agent of visceral leishmaniasis (VL), a lethal disease posing significant public health challenges globally. Existing anti-VL drugs have become increasingly ineffective due to rising…
- Marine algal TNF-α inhibitors explored by comparative docking and molecular dynamics simulations.: Marine ecosystems are rich in bioactive metabolites that represent a promising source of inhibitors targeting inflammatory signaling pathways. Among these, tumor necrosis factor-alpha (TNF-α) is a central pro-inflammatory cytokine driving chronic…
- Hepatotoxic Mechanisms of Polyethylene Terephthalate Microplastics Revealed by Network Toxicology, Molecular Docking, and In Vivo Validation.: Polyethylene terephthalate microplastics (PET-MPs) are emerging environmental pollutants, but the molecular mechanisms underlying their hepatotoxicity remain poorly understood. Here, we combined network toxicology with experimental validation to…
- Deciphering enzyme inhibition of thiazole assemblies for diabetes management via molecular docking, dynamic simulation, DFT and kinetic study: A computational therapeutic strategy.: Diabetes mellitus is a chronic metabolic disorder characterized by impaired insulin secretion and/or insulin resistance, leading to persistent hyperglycemia. In the present study, a series of novel fused imidazole-thiazole-derived thiazole compounds were…
- Mechanistic insights into PFAS derivatives-induced coronary heart disease and atherosclerotic renal artery stenosis via integrated network toxicology and molecular modeling.: Per- and polyfluoroalkyl substances (PFAS), such as PFHpA, PFOA, PFNA, and PFDA, are persistent environmental pollutants associated with multiple diseases. This study investigates the toxic mechanisms and pathways by which PFAS derivatives contribute to…
- Advancing protein engineering via organic chemistry.: Proteins are central to nearly all biological processes; their functions are tightly regulated by dynamic mechanisms such as covalent alterations; e.g., post-translational modifications (PTMs). These modifications can influence the protein’s structure,…
- LMO7-mediated ubiquitination of SIRT3 promotes osteoarthritis progression: an investigation using machine learning and molecular dynamics simulations.: Background This study aims to inform clinical decision-making by identifying metabolism-related biomarkers involved in the progression of osteoarthritis (OA). Four OA cartilage-related microarray datasets were downloaded from the GEO database. A…
- In silico and in vitro insights into stigmasterol targeting Keap1/Nrf2, Bcl-2/Bax and IKKβ/IκBα protein-protein interactions in Arsenic-induced toxicity.: Inorganic arsenic is a known neurotoxin that contributes to neurodevelopmental and neurodegenerative disorders by promoting oxidative stress, mitochondrial dysfunction and inflammation. It crosses the blood-brain barrier and accumulates in brain tissue….
🗓️ Thursday, Apr 23
- Exploring the Mechanism of Oral Cancer With Shikonin Based on the Network Pharmacology and Molecular Docking Technology.: Objectives To explore the underlying mechanisms of shikonin in treating oral cancer using network pharmacology and molecular docking methods. Materials and methods Targets of shikonin were obtained from the TCMSP, BATMAN, ChEMBL, PharmMapper and HERB…
- Unraveling the molecular interaction of hydroxytyrosol with human serum albumin via multi-spectroscopy, thermodynamic analysis, molecular docking and molecular dynamics simulation.: Hydroxytyrosol (HT) is a powerful antioxidant that scavenges free radicals and protects cells and also is one of the main active ingredients in functional foods. Recently, the consumption of HT has been increasing due to its excellent biological and…
- Integrated Network Pharmacology, Molecular Docking, and Experimental Validation Elucidating the Therapeutic Mechanism of Idesia polycarpa Crude Oil in Aluminum Chloride-Induced Alzheimer’s Rat Models.: While mounting evidence points to a potential link between industrial aluminum exposure and neurodegenerative diseases like Alzheimer’s disease (AD), the precise intervention strategies remain an area of active research. This study proposes a “multi-target…
- Network toxicology and molecular docking elucidation of oligoasthenospermia induced by bisphenol analogues: a comparative study of BPA, BPS, BPF, and BPAF.: Bisphenol A (BPA) substitutes are increasingly prevalent in consumer products, yet their potential to induce oligoasthenospermia (OAS) remains poorly understood. This study combined network toxicology, molecular docking, and 500-ns molecular dynamics (MD)…
- In-vitro analysis, metabolic profiling and in-silico molecular docking analysis shows antidiabetic potential of phytofabricated cerium oxide nanoparticles against diabetes related receptors.: Plants play a vital role in sustaining life on Earth, offering essential resources such as food, energy, shelter, and serving as a key source for drug development. Chemical pharmaceutics come with a range of disadvantages, including potential side effects,…
- Network Pharmacology, Molecular Docking, and Experimental Verification Employed to Elucidate the Potential Mechanisms of Bazi Bushen Capsule for the Treatment of Premature Ovarian Failure.: Introduction The aim of this study was to investigate the mechanism of BZBS in the treatment of POF using network pharmacology and molecular docking, and to validate it through in vivo experiments. Methods Network pharmacology was used to construct…
- Harnessing machine learning and multi-scale modeling to discover novel ALOX15 inhibitors from marine natural products.: ALOX15 is a key regulatory enzyme in multiple pathological processes including inflammation, cancer, and cardiovascular disease, rendering the development of potent inhibitors of this enzyme of significant clinical importance. This study aims to screen and…
- Comprehensive Exploration of Three Pistachio Varieties: Antidiabetic, Anticholinergic, Antioxidant Properties, Phytochemical Profile by LC-MS/MS, and Molecular Docking.: Pistachios (Pistacia vera L.) are a significant food that is added to many foods and also consumed as a snack. The kernel part is consumed very much. In this study, 53 phytochemical constituents of three pistachio varieties (Halebi, Kırmızı, and Uzun) were…
🗓️ Friday, Apr 24
- Molecular docking approaches in mycetoma: Toward improved patient management.: Mycetoma is a neglected tropical disease characterised by chronic, granulomatous inflammation of the subcutaneous tissues, often leading to disfigurement, disability, and significant socioeconomic burdens. Caused by a diverse array of bacterial and fungal…
- DiffDock-Glide: A Hybrid Physics-Based and Data-Driven Approach to Molecular Docking.: Recent years have seen a rise in applications of deep learning to problems in the molecular sciences. Among them, the diffusion model DiffDock stands out as a method for docking small molecules into protein binding sites. But DiffDock struggles to compete…
- Molecular docking and molecular dynamics simulations of compounds targeting GABAA receptor with potential relevance to anesthesia.: The gamma-aminobutyric acid type A (GABA A ) receptor is the primary mediator of inhibitory neurotransmission in the central nervous system and represents an important pharmacological target for sedative and anesthetic agents. However, many conventional…
- Exploring the mechanism of Jiaotai Pill in treating insomnia and erectile dysfunction based on network pharmacology, molecular docking, and molecular dynamics simulations.: Insomnia and erectile dysfunction (ED) exhibit a closely linked bidirectional association, often forming a vicious cycle. Current treatments focusing on single disorders show limited efficacy for this comorbidity. Jiaotai Pill, a classic traditional…
- Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and In Vitro Validation Reveal the Mechanism of Astragalus Root Against Diabetic Nephropathy: Background: /Objectives: Astragalus root, a traditional Chinese herbal remedy, has shown potential benefits against diabetic nephropathy (DN). However, the mechanisms driving its effects remain poorly understood. This study explored the molecular pathways…
- Exploring the mechanisms of luteolin in treating polycystic ovary syndrome and endometriosis via network pharmacology, molecular docking, and molecular dynamics simulation.: This study aims to elucidate the molecular mechanisms underlying luteolin’s therapeutic effects on polycystic ovary syndrome (PCOS) and endometriosis (EM), thereby providing a theoretical foundation for developing novel treatment strategies. An integrated…
- Pyrimidine Derivatives Containing a Thiosemicarbazide Moiety as Potential Antioxidant and α-Glucosidase Inhibitors: Synthesis, Bioactivity Evaluation, Molecular Docking, Molecular Dynamics Simulation, ADMET, and Drug-Likeness Studies.: In this study, a series of pyrimidine derivatives incorporating a thiosemicarbazide functional group were synthesized, and their structures were thoroughly characterized using 1 H NMR, 13 C NMR, and HRMS. Biological assays demonstrate that compound 5a…
- Exploring the Therapeutic Mechanism of Xiehuo Pingtu San in Treating Thyroid Eye Disease Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.: Background Xiehuo Pingtu San (XHPTS) has been shown to be safe and effective in treating thyroid eye disease (TED), yet its underlying mechanisms remain unclear. This study aimed to elucidate the active ingredients of XHPTS and their therapeutic mechanisms…
🛠️ Tools & Datasets
- 🛠 Tool: FunFOLD5 - Automated system for protein ligand-binding site prediction and function annotation.
- 🛠 Tool: MultiFOLD/IntFOLD - High-performance protein structure prediction and quality assessment server.
- 💾 Dataset: UniRef - Clustered protein sequence sets for fast similarity searches.
- 💾 Dataset: BFD - Big Fantastic Database for deep learning protein modeling.
- 🛠 Tool: Chai-1 - Multi-modal foundation model for molecular structure prediction.
- 🛠 Tool: Boltz-1 - Open-source biomolecular structure prediction model.
- 💾 Dataset: PDBbind - Binding affinity data with 3D structures of protein-ligand complexes.
- 💾 Dataset: BioLiP - Verified biologically relevant ligand-protein interactions.
- 🛠 Tool: ProteinSolver - Graph-based neural network for protein sequence design.
- 💾 Dataset: SIFTS - Residue-level mapping between PDB, UniProt, and other resources.
🤖 AI in Research Recap
- Demis Hassabis outlines Isomorphic Labs to speed drug discovery - NewsBytes: Demis Hassabis outlines Isomorphic Labs to speed drug discovery NewsBytes
- Google DeepMind CEO Demis Hassabis says “AI-designed drugs could replace decades-long process,”… - Moneycontrol.com: Google DeepMind CEO Demis Hassabis says “AI-designed drugs could replace decades-long process,”… Moneycontrol.com
- MHC Class II Peptide Binding Prediction: Challenges, AlphaFold 3, and ESM2 Explained - Pharmacy Times: MHC Class II Peptide Binding Prediction: Challenges, AlphaFold 3, and ESM2 Explained Pharmacy Times
- Beyond scaling thesis in biology: Why instrumentation, not compute, sets the ceiling for AI driven biomedicine - Dataconomy: Beyond scaling thesis in biology: Why instrumentation, not compute, sets the ceiling for AI driven biomedicine Dataconomy
- Demis Hassabis, co-founder and CEO of Google DeepMind, “AlphaGo’s Father,” will meet with President - 매일경제: Demis Hassabis, co-founder and CEO of Google DeepMind, “AlphaGo’s Father,” will meet with President 매일경제
- Doug Kojetin to present at Molecular Biophysics Training Program/Center for Structural Biology Seminar Series, April 28 - VUMC News: Doug Kojetin to present at Molecular Biophysics Training Program/Center for Structural Biology Seminar Series, April 28 VUMC News
- Structural insights into S1P receptor ligand binding: implications for targeted drug design - EurekAlert!: Structural insights into S1P receptor ligand binding: implications for targeted drug design EurekAlert!
- Glacios 3 cryo-TEM boosts cryo-EM access - Select Science: Glacios 3 cryo-TEM boosts cryo-EM access Select Science
🏢 Industry & Real-World Applications
- Theriva™ Biologics Announces Upcoming Presentation of - GlobeNewswire: Theriva™ Biologics Announces Upcoming Presentation of GlobeNewswire
- Pancreatic cancer study finds VCN-01 benefits patients with liver spread - Stock Titan: Pancreatic cancer study finds VCN-01 benefits patients with liver spread Stock Titan
- Trevi raises $150M; Spain and Boston set up biotech fund - Endpoints News: Trevi raises $150M; Spain and Boston set up biotech fund Endpoints News
- Obesity biotech Kailera’s record-breaking IPO - pharmaphorum: Obesity biotech Kailera’s record-breaking IPO pharmaphorum
- BBCQ Stock Price, News & Analysis - Stock Titan: BBCQ Stock Price, News & Analysis Stock Titan
- Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone - simplywall.st: Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone simplywall.st
- ATUM Names Genentech and Eli Lilly Veteran Gavin Barnard as Chief Scientific Officer - citybiz: ATUM Names Genentech and Eli Lilly Veteran Gavin Barnard as Chief Scientific Officer citybiz
- Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies - Genetic Engineering and Biotechnology News: Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies Genetic Engineering and Biotechnology News
- FDA Accepts Supplemental Biologics Application for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America: FDA Accepts Supplemental Biologics Application for Gazyva® in Systemic Lupus Erythematosus Lupus Foundation of America
- Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer - Newswise: Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer Newswise
- Axios Live: Biotech advances face policy and funding obstacles, industry leaders say - Axios: Axios Live: Biotech advances face policy and funding obstacles, industry leaders say Axios
- AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada - BioSpace: AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada BioSpace
- Theriva Biologics stock surges on AACR cancer trial data - Investing.com: Theriva Biologics stock surges on AACR cancer trial data Investing.com
- AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL - The Manila Times: AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL The Manila Times
- AbbVie Provides Update on TrenibotulinumtoxinE Biologics License Application in the U.S. - Investing News Network: AbbVie Provides Update on TrenibotulinumtoxinE Biologics License Application in the U.S. Investing News Network
- Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing - simplywall.st: Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing simplywall.st
- Fierce Biotech Fundraising Tracker ‘26: Tortugas’ $106M beachhead; Ray shines with $125M - Fierce Biotech: Fierce Biotech Fundraising Tracker ‘26: Tortugas’ $106M beachhead; Ray shines with $125M Fierce Biotech
- Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride - statnews.com: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride statnews.com
💼 Jobs & Opportunities
- Biology & Python Expert - Freelance AI Trainer - Workable (Workable)
- Postdoctoral Fellow - Cowpea Plant Breeding and Genetics - Workable (Workable)
- Memorial Sloan Kettering Cancer Center hiring Bioinformatics Software Engineer in New York, NY - LinkedIn (Bioinformatics Careers)
- Acrivon Therapeutics, Inc. hiring Senior/Principal Scientist, Bioinformatics in Watertown, MA - LinkedIn (Bioinformatics Careers)
- Full-Time, Teaching-Track Faculty Position in Quantitative and Computational Biology - LinkedIn (Bioinformatics Careers)
- Owen Thomas | B Corp™ hiring Principal Machine Learning Scientist | ADMET/Structural Biology | Series A - Drug discovery Platform | Fully Remote, EU | Base Salary Up to £160,000K, plus early equity+benefits in United Kingdom - LinkedIn (Bioinformatics Careers)
📅 Events
Enjoyed this digest? Subscribe above to get these dailies in your inbox every morning.